SEC opens inquiry into Wall Street's SPAC mania — report; A China-based gene therapy player now has $80M more in the bank
The SPAC mania has intensified not just in biotech but throughout the market. And it’s caught so much fire that now the SEC has reportedly …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
